| 1 |
19817724 | Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. | 2010 Jan 15 |
1 |
| 2 |
17377643 | N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulphasalazine in the treatment of inflammatory bowel disease. | 2007 Mar |
2 |
| 3 |
15032315 | N-acetyltransferase 2 genotype-related efficacy of sulfasalazine in patients with rheumatoid arthritis. | 2004 Feb |
1 |
| 4 |
12186410 | N-acetyltransferase 2 genotype-related sulfapyridine acetylation and its adverse events. | 2002 Aug |
2 |
| 5 |
11642327 | N-Acetyltransferase 2 genotype correlates with sulfasalazine pharmacokinetics after multiple dosing in healthy Japanese subjects. | 2001 Oct |
1 |
| 6 |
10194945 | [Clinical effect of various 5-ASA preparations in ulcerative colitis]. | 1999 Feb 15 |
1 |
| 7 |
1351726 | The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells. | 1992 Jun 9 |
1 |
| 8 |
1673814 | [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue]. | 1991 |
3 |
| 9 |
1970478 | [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration]. | 1990 |
1 |
| 10 |
2902897 | Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action? | 1988 Oct |
1 |
| 11 |
2873245 | A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. | 1986 Apr |
1 |
| 12 |
2867770 | Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites. | 1985 |
1 |
| 13 |
6121576 | The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. | 1982 Apr |
1 |
| 14 |
6152489 | Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age. | 1982 |
1 |
| 15 |
33552 | Hemolysis during salicylazosulfapyridine therapy. | 1978 Nov |
1 |